/Companies

Cptx

Founded 2021 · 49 employees on LinkedIn · 1 known investors

Find your way into Cptx

Sign up to see every warm intro you have to Cptx

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Cptx team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

CPTx is a genetic medicines company developing in vivo therapies using immune-silent, redosable single-stranded DNA technology. The company focuses on creating safe, durable treatments, with a lead program in CAR-T cell therapy and collaborations on novel genetic medicines.

Founders & leadership

HDHendrik Dietz
Hendrik DietzScientific Co-Founder at LogicInk

Investors · 1

Frequently asked questions

What does Cptx do?
CPTx is a genetic medicines company developing in vivo therapies using immune-silent, redosable single-stranded DNA technology. The company focuses on creating safe, durable treatments, with a lead program in CAR-T cell therapy and collaborations on novel genetic medicines.
Who are Cptx's investors?
Cptx's investors include BlueYard Capital.